Results 61 to 70 of about 2,602,735 (305)

Thrombotic events and rebleeding after hemorrhage in patients taking direct oral anticoagulants for non-valvular atrial fibrillation.

PLoS ONE, 2021
Several direct oral anticoagulants have been developed to prevent cardiogenic thrombosis in patients with atrial fibrillation, on the other hand, have the complication of bleeding.
Daisuke Yanagisawa, Koichiro Abe, Hirohito Amano, Shogo Komatsuda, Taku Honda, Daisuke Manabe, Hirosada Yamamoto, Ken Kozuma, Shinya Kodashima, Yoshinari Asaoka, Takatsugu Yamamoto, Atsushi Tanaka   +11 more
doaj   +1 more source

Oral Anticoagulation and Functional Outcome after Intracerebral Hemorrhage

Annals of Neurology, 2017
Oral anticoagulation treatment (OAT) resumption is a therapeutic dilemma in intracerebral hemorrhage (ICH) care, particularly for lobar hemorrhages related to amyloid angiopathy.
A. Biffi, J. Kuramatsu, A. Leasure, H. Kamel, Christina Kourkoulis, K. Schwab, A. Ayres, J. Elm, M. Gurol, Steven M. Greenberg, A. Viswanathan, C. Anderson, S. Schwab, J. Rosand, F. Testai, D. Woo, H. Huttner, K. Sheth   +17 more
semanticscholar   +1 more source

Recurrent Hypothermia and Autonomic Dysfunction Secondary to Shapiro Syndrome

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT A 44‐year‐old man presented with recurrent hypothermia, diaphoresis and hypertension. Extensive investigation for infectious, inflammatory, metabolic and endocrine aetiologies was negative. MR scan of the brain demonstrated no lesions but revealed callosal dysgenesis, consistent with Shapiro syndrome.
Naveen Kumar, Jeremy Johnson, Susanne Watkins, Eoin Mulroy   +3 more
wiley   +1 more source

No child should suffer from vitamin K deficiency‐induced bleeding disorders

Clinical Case Reports, 2022
We encountered an 11‐day‐old male neonate with vitamin K deficiency‐induced intracranial hemorrhage, despite receiving oral vitamin K2 (menaquinone‐4) prophylaxis according to Japanese guidelines.
Masazumi Miyahara, Kyoko Osaki
doaj   +1 more source

Outcome of intracerebral hemorrhage associated with different oral anticoagulants

Neurology, 2017
Objective: In an international collaborative multicenter pooled analysis, we compared mortality, functional outcome, intracerebral hemorrhage (ICH) volume, and hematoma expansion (HE) between non–vitamin K antagonist oral anticoagulation–related ICH ...
D. Wilson, D. Seiffge, C. Traenka, G. Basir, J. Purrucker, T. Rizos, O. Sobowale, Hanne Sallinen, S. Yeh, Teddy Y. Wu, M. Ferrigno, R. Houben, Floris H. B. M. Schreuder, L. Perry, J. Tanaka, M. Boulanger, R. Al‐Shahi Salman, H. Jäger, G. Ambler, C. Shakeshaft, Y. Yakushiji, P. Choi, J. Staals, C. Cordonnier, J. Jeng, R. Veltkamp, D. Dowlatshahi, S. Engelter, A. Parry-Jones, A. Meretoja, D. Werring   +30 more
semanticscholar   +1 more source

Interaction of Intraprocedural Antiplatelets and Intravenous Thrombolysis in Acute Intracranial Stenting: RESISTANT Registry Subanalysis

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Introduction/Objective Acute intracranial stenting during endovascular thrombectomy (EVT) for ischemic stroke requires intraprocedural antiplatelet therapy (APT) to maintain patency. However, the hemorrhagic risk of combining APT with intravenous thrombolysis (IVT) remains uncertain.
Aaron Rodriguez‐Calienes, Leonardo Cruz‐Criollo, Eric Kontowicz, Marta Olivé‐Gadea, Francesco Diana, Johannes Kaesmacher, Adnan Mujanovic, Serdar Geyik, Songul Senadim, Amedeo Cervo, Andrea Salcuni, Mariangela Piano, Manuel Moreu, Alfonso López‐Frías, Ameer E. Hassan, Samantha Miller, Elena Zapata‐Arriaza, Asier de Albóniga‐Chindurza, Mauro Bergui, Stefano Molinaro, João André Sousa, Fábio Gomes, João Sargento‐Freitas, Andrea Alexandre, Alessandro Pedicelli, Jeremy Hofmeister, Paolo Machi, Luca Scarcia, Erwah Kalsoum, Jose Amorim, Torcato Meira, Leonardo Renieri, Francesco Capasso, Daniele Romano, Eduardo Bárcena‐Ruiz, David Seoane, Mohamad Abdalkader, Piers Klein, Thanh N. Nguyen, Catarina Perry da Câmara, Anderson Brito, Nashwa Abdelhakim, Isabel Fragata, Dileep R. Yavagal, Jude H. Charles, Jose Rodriguez Castro, Pedro Vega, Atilla Özcan Özdemir, Zehra Uysal Kocabaş, Stanislas Smajda, Sadiq Al Salman, Jane Khalife, Tudor G. Jovin, Francesco Biraschi, Francesca Richetti, Pedro Castro, Luis Albuquerque, Adnan Siddiqui, Vinay Jaikumar, Pedro Navia, Nikolaos Ntoulias, Marios Psychogios, Mariano Velo, Joaquín Zamarro, Gonzalo de Paco, Yazan Ashouri, Mohammad AlMajali, Juan F. Arenillas, Alicia Sierra, Michele Romoli, João Pedro Marto, Shadi Yaghi, Marc Ribo, Alejandro Tomasello, Manuel Requena, Santiago Ortega‐Gutierrez   +75 more
wiley   +1 more source

Oral tranexamic acid for acute management of active bleeding from iris microhemangiomatosis: A case report

American Journal of Ophthalmology Case Reports
Purpose: to report a case of active intraocular bleeding caused by iris microhemangiomatosis managed with oral tranexamic acid. Observations: an 80-year-old male was referred to our emergency department for acute intraocular bleeding.
Dario Marangoni, Antonio Gemito, Serena Milan, Daniele Tognetto   +3 more
doaj   +1 more source

Intravenous Thrombolysis With Alteplase at 0.6 mg/kg in Patients With Ischemic Stroke Taking Direct Oral Anticoagulants

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2022
Background We elucidated the safety of treatment with alteplase at 0.6 mg/kg within 24 hours for patients on direct oral anticoagulants (DOACs) before ischemic stroke onset.
Takashi Okada, Takeshi Yoshimoto, Shinichi Wada, Sohei Yoshimura, Tetsuya Chiba, Shuhei Egashira, Shunsuke Kimura, Masayuki Shiozawa, Manabu Inoue, Masafumi Ihara, Kazunori Toyoda, Hiroshi Takashima, Masatoshi Koga   +12 more
doaj   +1 more source

Neuroimaging and clinical outcomes of oral anticoagulant–associated intracerebral hemorrhage

Annals of Neurology, 2018
Whether intracerebral hemorrhage (ICH) associated with non–vitamin K antagonist oral anticoagulants (NOAC‐ICH) has a better outcome compared to ICH associated with vitamin K antagonists (VKA‐ICH) is uncertain.
G. Tsivgoulis, D. Wilson, A. Katsanos, J. Sargento-Freitas, Cláudia Marques-Matos, E. Azevedo, Tomohide Adachi, Christian Brelie, Y. Aizawa, H. Abe, H. Tomita, K. Okumura, J. Hagii, D. Seiffge, V. Lioutas, C. Traenka, P. Varelas, G. Basir, C. Krogias, J. Purrucker, V. Sharma, T. Rizos, R. Mikulík, O. Sobowale, K. Barlinn, Hanne Sallinen, Nitin Goyal, S. Yeh, T. Karapanayiotides, Teddy Y. Wu, K. Vadikolias, M. Ferrigno, G. Hadjigeorgiou, R. Houben, S. Giannopoulos, Floris H. B. M. Schreuder, Jason J. Chang, L. Perry, Maximilian Mehdorn, J. Marto, J. Pinho, J. Tanaka, M. Boulanger, R. Al‐Shahi Salman, H. Jäger, C. Shakeshaft, Y. Yakushiji, P. Choi, J. Staals, C. Cordonnier, J. Jeng, R. Veltkamp, D. Dowlatshahi, S. Engelter, A. Parry-Jones, A. Meretoja, P. Mitsias, A. Alexandrov, G. Ambler, D. Werring   +59 more
semanticscholar   +1 more source

Effects of Add‐On Icosapent Ethyl With Standard Treatment on Functional Outcomes and Inflammatory Biomarkers in Acute Ischemic Stroke: A Blinded Randomized Controlled Trial

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Background Ischemic stroke, a major cause of mortality and long‐term disability, results from the abrupt cessation of cerebral blood flow due to vascular occlusion or rupture. Icosapent Ethyl (EPA‐EE), approved for hypertriglyceridemia, has anti‐inflammatory and antithrombotic properties that may lessen ischemic damage.
Mitra Mahmoudi Meymand, Seyed Hossein Aghamiri, Saeed Mohmammad Soleymani, Shadiyeh Bararpoor Poshkohi, Samaneh Masoudi, Hadi Esmaily   +5 more
wiley   +1 more source